SCOPUS 정보 검색 플랫폼

Current Opinion in Pharmacology

Volumn 2, Issue 4, 2002, Pages 433-439

Therapeutic use of interleukin-2 in HIV-infected patients

(2) Pau, Alice K a Tavel, Jorge A b

a NATIONAL INSTITUTES OF HEALTH (United States)

b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 2; NUCLEOSIDE DERIVATIVE; RECOMBINANT INTERLEUKIN 2; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACUTE KIDNEY FAILURE; ARTICLE; BONE MARROW SUPPRESSION; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; GASTROINTESTINAL SYMPTOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MAXIMUM TOLERATED DOSE; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SURVIVAL RATE; T LYMPHOCYTE; VIRUS REPLICATION; ANIMAL; IMMUNOLOGY; REVIEW;

ANIMALS; HIV INFECTIONS; HUMANS; INTERLEUKIN-2;

EID: 0036667391 PISSN: 14714892 EISSN: None Source Type: Journal
DOI: 10.1016/S1471-4892(02)00177-7 Document Type: Review

Times cited : (18)

References (33)

1
- 2642709177
- Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
- (1998) N. Engl. J. Med , vol.338 , pp. 853-860
- Pallela F.J., Jr.¹ Delaney, K.M.² Moorman, A.C.³ Loveless, M.O.⁴ Fuhrer, J.⁵ Satten, G.A.⁶ Aschman, D.J.⁷ Holmberg, S.D.⁸

2
- 0009521781
- Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group
- (1999) Lancet , vol.353 , pp. 1293-1298
- Weverling, G.J.¹ Mocroft, A.² Ledergerber, B.³ Kirk, O.⁴ Gonzales-Lahoz, J.⁵ d'Arminio Monforte, A.⁶ Proenca, R.⁷ Phillips, A.N.⁸ Lundgren, J.D.⁹ Reiss, P.¹⁰

3
- 0035873218
- Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 during 1995-1999
- (2001) Clin. Infect. Dis , vol.32 , pp. 1487-1493
- Valdez, H.¹ Chowdhry, T.K.² Asaad, R.³ Woolley, U.⁴ Davis, T.⁵ Davidson, R.⁶ Beinker, N.⁷ Gripshover, B.M.⁸ Salata, R.A.⁹ McComsey, G.¹⁰

4
- 0033803407
- Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy
- (2000) Clin. Infect. Dis , vol.30 , Issue.SUPPL. 1
- Kaplan, J.E.¹ Hanson, D.² Dworkin, M.S.³ Frederick, T.⁴ Bertolli, J.⁵ Lindegren, M.L.⁶ Holmberg, S.⁷ Jones, J.L.⁸

5
- 0032824724
- Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy
- (1999) J. Infect. Dis , vol.180 , pp. 865-870
- Parkin, N.T.¹ Lie, Y.S.² Hellmann, N.³ Markowitz, M.⁴ Bonhoeffer, S.⁵ Ho, D.D.⁶ Petropoulos, C.J.⁷

6
- 0034699898
- Adverse effects of antiretroviral therapy
- (2000) Lancet , vol.356 , pp. 1423-1430
- Carr, A.¹ Cooper, D.A.²

7
- 0029923736
- Interleukin-2 and human immunodeficiency virus infection: Pathogenic mechanisms and potential for immunologic enhancement
- (1996) Immunol. Res , vol.15 , pp. 1-15
- Kinter, A.¹ Fauci, A.S.²

8
- 0028912032
- Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection
- (1995) N. Engl. J. Med , vol.332 , pp. 567-575
- Kovacs, J.A.¹ Baseler, M.² Dewar, R.J.³ Vogel, S.⁴ Davey R.T., Jr.⁵ Falloon, J.⁶ Polis, M.A.⁷ Walker, R.D.⁸ Stevens, R.⁹ Salzman, N.P.¹⁰

9
- 0013610170
- Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
- (1996) N. Engl. J. Med , vol.335 , pp. 1350-1356
- Kovacs, J.A.¹ Vogel, S.² Albert, J.M.³ Falloon, J.⁴ Davey, R.T.⁵ Walker, R.E.⁶ Polis, M.A.⁷ Spooner, K.⁸ Metcalf, J.A.⁹ Baseler, M.¹⁰

10
- 0031680651
- Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: A randomized, controlled, multicenter study
- (1998) J. Infect. Dis , vol.178 , pp. 992-999
- Carr, A.¹ Emery, S.² Lloyd, A.³ Hoy, J.⁴ Garsia, R.⁵ French, M.⁶ Stewart, G.⁷ Fyfe, G.⁸ Cooper, D.A.⁹

11
- 0003054117
- Duration of Proleukin IL-2 therapy is more important than total dose in achieving CD4 expansion
- (abstract I149] In Abstracts of the 36th Interscience conference on Antimicrobial Agents and Chemotherapy: 1996 Sep 15-18; New Orleans. Washington DC: American Society for Microbiology
- (1996) , pp. 86
- Saravolatz, L.¹ Mitsuyasu, R.² Sneller, M.N.³

12
- 0033836422
- Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease
- (2000) J. Infect. Dis , vol.182 , pp. 428-434
- Emery, S.¹ Capra, W.B.² Cooper, D.A.³ Mitsuyasu, R.T.⁴ Kovacs, J.A.⁵ Vig, P.⁶ Smolski, M.⁷ Saravolatz, D.⁸ Lane, H.C.⁹ Fyfe, G.A.¹⁰

13
- 0029766860
- Pharmacokinetics and pharmacodynamics of subcutaneous interleukin-2 in HIV-infected patients
- (1996) Pharmacotherapy , vol.16 , pp. 754-759
- Piscitelli, S.C.¹ Wells, M.J.² Metcalf, J.A.³ Baseler, M.⁴ Stevens, R.A.⁵ Davey R.T., Jr.⁶

14
- 16944364282
- Subcutaneous administration of interleukin-2 in human immunodeficiency virus type-1 infected persons
- (1997) J. Infect. Dis , vol.175 , pp. 781-789
- Davey R.T., Jr.¹ Chaitt, D.C.² Piscitelli, S.C.³ Wells, M.⁴ Kovacs, J.A.⁵ Walker, R.E.⁶ Falloon, J.⁷ Polis, M.A.⁸ Metcalf, J.A.⁹ Masur, H.¹⁰

15
- 0001027244
- A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection
- (1999) J. Infect. Dis , vol.179 , pp. 849-858
- Davey R.T., Jr.¹ Chaitt, D.G.² Albert, J.³ Piscitelli, S.C.⁴ Kovacs, J.⁵ Walker, R.E.⁶ Falloon, J.⁷ Polis, M.A.⁸ Metcalf, J.A.⁹ Masur, H.¹⁰

16
- 0035822985
- Immunological and virological effects of long term IL-2 therapy in HIV-infected patients
- ANRS 048 Study Group
- (2001) AIDS , vol.15 , pp. 1729-1731
- Gougeon, M.-L.¹ Rouzioux, C.² Liberman, I.³ Burgard, M.⁴ Taoufik, Y.⁵ Viard, J.-P.⁶ Bouchenafa, K.⁷ Capitant, C.⁸ Delfraissy, J.-F.⁹ Levy, Y.¹⁰

17
- 0032958616
- Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection
- (1999) J. AIDS , vol.20 , pp. 20-27
- Simonelli, C.¹ Zanussi, S.² Sandri, S.³ Comar, M.⁴ Lucenti, A.⁵ Talamini, R.⁶ Bortolin, M.T.⁷ Giacca, M.⁸ DePaoli, P.⁹ Tirelli, U.¹⁰

18
- 0034129968
- A randomized, controlled, Phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell Vanguard Study Group
- (2000) J. Infect. Dis , vol.181 , pp. 1614-1621
- Losso, M.H.¹ Belloso, W.H.² Emery, S.³ Benetucci, J.A.⁴ Cahn, P.E.⁵ Lasala, M.C.⁶ Lopardo, G.⁷ Salomon, H.⁸ Saracco, M.⁹ Nelson, E.¹⁰

19
- 0033526641
- Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: A randomized controlled trial
- (1999) Lancet , vol.353 , pp. 1923-1929
- Levy, Y.¹ Capitant, C.² Houhou, S.³ Carriere, I.⁴ Viard, J.P.⁵ Goujard, C.⁶ Gastaut, J.A.⁷ Oksenhendler, E.⁸ Boumsell, L.⁹ Gomard, E.¹⁰

20
- 0034222019
- Teaching HIV-infected outpatients the self-administration of subcutaneous interleukin-2 and strategies for symptom management
- (2000) J. Assoc. Nurses AIDS Care , vol.11 , pp. 97-103
- Lloyd, M.¹ Young, K.A.²

21
- 0037169169
- Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides
- (2002) AIDS , vol.16 , pp. 245-249
- Barreiro, P.¹ Soriano, V.² Casas, E.³ Gonzalez-Lahoz, J.⁴

22
- 0034641205
- Immune restoration with antiretroviral therapies - Implications for clinical management
- (2000) J. Am. Med. Assoc , vol.284 , pp. 223-228
- Lederman, M.M.¹ Valdez, H.²

23
- 0035873085
- Efficacy of low-dose intermittent subcutaneous interleukin (IL)-2 in antiviral drug-experienced human immunodeficiency virus-infected persons with detectable virus load: A controlled study of 3 IL-2 regimens with therapy
- (2001) J. Infect. Dis , vol.183 , pp. 1476-1484
- Tambussi, G.¹ Ghezzi, S.² Nozza, S.³ Vallanti, G.⁴ Magenta, L.⁵ Guffanti, M.⁶ Brambilla, A.⁷ Vicenzi, E.⁸ Carrera, P.⁹ Racca, S.¹⁰

24
- 0036500935
- 3: CPCRA 059
- (2002) J. AIDS , vol.29 , pp. 221-231
- Abrams, D.I.¹ Bebchuk, J.D.² Denning, E.T.³ Davey, R.T.⁴ Fox, L.⁵ Lane, H.C.⁶ Sampson, J.⁷ Verheggen, R.⁸ Zeh, D.⁹ Markowitz, N.P.¹⁰

25
- 0004781509
- Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy - A randomized controlled trial
- (2000) J. Am. Med. Assoc , vol.284 , pp. 183-189
- Davey R.T., Jr.¹ Murphy, R.L.² Graziano, F.M.³ Boswell, S.L.⁴ Pavia, A.T.⁵ Cancio, M.⁶ Nadler, J.P.⁷ Chaitt, D.G.⁸ Dewar, R.L.⁹ Sahner, D.K.¹⁰

26
- 0035282639
- Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4-cell counts increase only slightly in response to combined antiretroviral treatment
- (2001) J. Infect. Dis , vol.183 , pp. 730-735
- David, D.¹ Nait-Ighil, L.² Dupont, B.³ Maral, J.⁴ Gachot, B.⁵ Theze, J.⁶

27
- 0033017140
- Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with ≤250/ μL CD4 T cells and undetectable plasma virus load
- (1999) J. Infect. Dis , vol.180 , pp. 56-60
- Arnó, A.¹ Ruiz, L.² Juan, M.³ Jou, A.⁴ Balague, M.⁵ Zayat, M.K.⁶ Marfil, S.⁷ Martinez-Picado, J.⁸ Martinez, M.A.⁹ Romeu, J.¹⁰

28
- 7844229880
- Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients
- (1998) AIDS , vol.12
- Hengge, U.R.¹ Goos, M.² Esser, S.³ Exner, V.⁴ Dötterer, J.⁵ Wiehler, H.⁶ Borchard, C.⁷ Müller, K.⁸ Beckmann, A.⁹ Eppner, M.-T.¹⁰

29
- 0034331263
- + patients: A randomized controlled trial
- (2000) HIV Clinical Trials , vol.1 , pp. 1-15
- Lalezari, J.P.¹ Beal, J.A.² Ruane, P.J.³ Cohen, C.J.⁴ Jacobson, E.L.⁵ Sundin, D.⁶ Leong, W.P.⁷ Raffanti, S.P.⁸ Wheeler, D.A.⁹ Anderson, R.D.¹⁰

30
- 0035905882
- Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy
- (2001) N. Engl. J. Med , vol.344 , pp. 168-174
- Lederberger, B.¹ Mocroft, A.² Reiss, P.³ Furrer, H.⁴ Kirk, O.⁵ Bickel, M.⁶ Uberti-Foppa, C.⁷ Pradier, C.⁸ D'Arminio Monforte, A.⁹ Schneider, M.M.¹⁰

31
- 0034601814
- + cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team
- (2000) Ann. Intern. Med , vol.133 , pp. 493-503
- Currier, J.S.¹ Williams, P.L.² Koletar, S.L.³ Cohn, S.E.⁴ Murphy, R.L.⁵ Heald, A.E.⁶ Hafner, R.⁷ Bassily, E.L.⁸ Lederman, H.M.⁹ Knirsch, C.¹⁰

32
- 0035019084
- Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy
- (2001) Eur. J. Immunol , vol.31 , pp. 1351-1360
- Kovacs, J.A.¹ Vogel, S.² Metcalf, J.A.³ Baseler, M.⁴ Stevens, R.⁵ Adelsberger, J.⁶ Lempicki, R.⁷ Hengel, R.L.⁸ Sereti, I.⁹ Lambert, L.¹⁰

33
- 0031439413
- + subjects
- (1997) J. Clin. Invest , vol.100 , pp. 2737-2743
- De Paoli, P.¹ Zanussi, S.² Simonelli, C.³ Bortolin, M.T.⁴ D'Andrea, M.⁵ Crepaldi, C.⁶ Talamini, R.⁷ Comar, M.⁸ Giacca, M.⁹ Tirelli, U.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.